Valion Bio (VBIO) Current Taxes (2023 - 2025)

Valion Bio (VBIO) posted quarterly Current Taxes of $73000.0 for Q3 2025, up 21.67% quarter-over-quarter from $60000.0 in Q2 2025.

Valion Bio (VBIO) Current Taxes (2023 - 2025) Analysis & Trends

Valion Bio's Current Taxes history runs 3 years deep, the most recent figure standing at $73000.0 for Q3 2025.

In Q3 2025, Current Taxes changed N/A year-over-year to $73000.0; the TTM figure through Sep 2025 stood at $73000.0 (changed N/A YoY), while the FY2023 annual figure was $160000.0, changed N/A from the prior year.
Current Taxes for Q3 2025 stood at $73000.0, up from $60000.0 in the prior quarter.
The five-year high for Current Taxes was $160000.0 in Q4 2023, with the low at $20000.0 in Q1 2024.
The 3-year median for Current Taxes is $60000.0 (2025), against an average of $72600.0.
Peak annual rise in Current Taxes reached 150.0% in 2025, while the deepest fall reached 150.0% in 2025.
Valion Bio's Current Taxes stood at $160000.0 in 2023, then tumbled by 87.5% to $20000.0 in 2024, then soared by 265.0% to $73000.0 in 2025.
Business Quant data shows VBIO's Current Taxes at $73000.0 in Q3 2025, $60000.0 in Q2 2025, and $50000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	49.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	76.36 Mn
10	Valion Bio	420,133.64	-1.78 Mn	-45,000.00	-

Download Data